Journal of Community Hospital Internal Medicine Perspectives (Jul 2020)

Evidence-based supportive care in multiple myeloma

  • Anum Qureshi,
  • Muhammad Junaid Tariq,
  • Zunairah Shah,
  • Muhammad Abu Zar,
  • Shehroz Aslam,
  • Abdul Rafae,
  • Madeeha Shafqat,
  • Mustafa Nadeem Malik,
  • Muhammad Salman Faisal,
  • Faiz Anwer

DOI
https://doi.org/10.1080/20009666.2020.1771124
Journal volume & issue
Vol. 10, no. 4
pp. 313 – 317

Abstract

Read online

Multiple myeloma (MM) is a hematological malignancy characterized by an abnormal clone of plasma cells in the bone marrow. MM and its therapy increase the risk of complications like anemia, osteolytic lesions, pain, infections, and renal abnormalities in MM patients. Supportive care for MM patients improves the quality of life. Treatment with bisphosphonates decreases skeletal-related events. Vertebroplasty and kyphoplasty are done in cases of vertebral compression fractures. Prophylactic antibiotics and antivirals can decrease infections related to morbidity. Plasmapheresis in patients with renal dysfunctions decreases dialysis dependency and improve quality of life.

Keywords